JPH01218595A - Production of tropan-based alkaloid - Google Patents
Production of tropan-based alkaloidInfo
- Publication number
- JPH01218595A JPH01218595A JP4223388A JP4223388A JPH01218595A JP H01218595 A JPH01218595 A JP H01218595A JP 4223388 A JP4223388 A JP 4223388A JP 4223388 A JP4223388 A JP 4223388A JP H01218595 A JPH01218595 A JP H01218595A
- Authority
- JP
- Japan
- Prior art keywords
- medium
- alkaloid
- tissue
- present
- plant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 12
- 229930013930 alkaloid Natural products 0.000 title abstract description 26
- 150000003797 alkaloid derivatives Chemical class 0.000 title abstract description 14
- 150000002993 phenylalanine derivatives Chemical class 0.000 claims abstract description 14
- 229930004668 tropane alkaloid Natural products 0.000 claims description 16
- 150000003813 tropane derivatives Chemical class 0.000 claims description 14
- 238000012258 culturing Methods 0.000 claims description 6
- 241000196324 Embryophyta Species 0.000 abstract description 25
- 229930000680 A04AD01 - Scopolamine Natural products 0.000 abstract description 8
- STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 abstract description 8
- STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 abstract description 8
- STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 abstract description 8
- 229960002646 scopolamine Drugs 0.000 abstract description 8
- 239000003375 plant hormone Substances 0.000 abstract description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract description 5
- 229910052799 carbon Inorganic materials 0.000 abstract description 5
- 125000000217 alkyl group Chemical group 0.000 abstract description 3
- 241001469190 Duboisia myoporoides Species 0.000 abstract description 2
- 229930006000 Sucrose Natural products 0.000 abstract description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 abstract description 2
- 239000000203 mixture Substances 0.000 abstract description 2
- 239000005720 sucrose Substances 0.000 abstract description 2
- QVWDCTQRORVHHT-UHFFFAOYSA-N tropone Chemical compound O=C1C=CC=CC=C1 QVWDCTQRORVHHT-UHFFFAOYSA-N 0.000 abstract 3
- DQLHSFUMICQIMB-VIFPVBQESA-N (2s)-2-amino-3-(4-methylphenyl)propanoic acid Chemical compound CC1=CC=C(C[C@H](N)C(O)=O)C=C1 DQLHSFUMICQIMB-VIFPVBQESA-N 0.000 abstract 1
- 150000003862 amino acid derivatives Chemical class 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 150000001455 metallic ions Chemical class 0.000 abstract 1
- 239000002609 medium Substances 0.000 description 44
- 238000000034 method Methods 0.000 description 11
- XLRPYZSEQKXZAA-OCAPTIKFSA-N tropane Chemical compound C1CC[C@H]2CC[C@@H]1N2C XLRPYZSEQKXZAA-OCAPTIKFSA-N 0.000 description 10
- 229930004006 tropane Natural products 0.000 description 10
- 239000007788 liquid Substances 0.000 description 9
- XWHHYOYVRVGJJY-QMMMGPOBSA-N 4-fluoro-L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(F)C=C1 XWHHYOYVRVGJJY-QMMMGPOBSA-N 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 239000000306 component Substances 0.000 description 7
- RKUNBYITZUJHSG-FXUDXRNXSA-N (S)-atropine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@H]3CC[C@@H](C2)N3C)=CC=CC=C1 RKUNBYITZUJHSG-FXUDXRNXSA-N 0.000 description 6
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 6
- 210000004748 cultured cell Anatomy 0.000 description 6
- 229930005342 hyoscyamine Natural products 0.000 description 6
- 229960003210 hyoscyamine Drugs 0.000 description 6
- 206010020649 Hyperkeratosis Diseases 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 229940088594 vitamin Drugs 0.000 description 5
- 229930003231 vitamin Natural products 0.000 description 5
- 235000013343 vitamin Nutrition 0.000 description 5
- 239000011782 vitamin Substances 0.000 description 5
- 229920001817 Agar Polymers 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- NIGWMJHCCYYCSF-UHFFFAOYSA-N Fenclonine Chemical compound OC(=O)C(N)CC1=CC=C(Cl)C=C1 NIGWMJHCCYYCSF-UHFFFAOYSA-N 0.000 description 4
- NWBJYWHLCVSVIJ-UHFFFAOYSA-N N-benzyladenine Chemical compound N=1C=NC=2NC=NC=2C=1NCC1=CC=CC=C1 NWBJYWHLCVSVIJ-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- -1 ammonium ions Chemical class 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- JTEDVYBZBROSJT-UHFFFAOYSA-N indole-3-butyric acid Chemical compound C1=CC=C2C(CCCC(=O)O)=CNC2=C1 JTEDVYBZBROSJT-UHFFFAOYSA-N 0.000 description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 4
- 241000208296 Datura Species 0.000 description 3
- 241001469188 Duboisia Species 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- UQHKFADEQIVWID-UHFFFAOYSA-N cytokinin Natural products C1=NC=2C(NCC=C(CO)C)=NC=NC=2N1C1CC(O)C(CO)O1 UQHKFADEQIVWID-UHFFFAOYSA-N 0.000 description 3
- 239000004062 cytokinin Substances 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- PRPINYUDVPFIRX-UHFFFAOYSA-N 1-naphthaleneacetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CC=CC2=C1 PRPINYUDVPFIRX-UHFFFAOYSA-N 0.000 description 2
- 239000005631 2,4-Dichlorophenoxyacetic acid Substances 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241001106067 Atropa Species 0.000 description 2
- 240000004204 Brugmansia arborea Species 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- STECJAGHUSJQJN-USLFZFAMSA-N LSM-4015 Chemical compound C1([C@@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-USLFZFAMSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- QXYJCZRRLLQGCR-UHFFFAOYSA-N dioxomolybdenum Chemical compound O=[Mo]=O QXYJCZRRLLQGCR-UHFFFAOYSA-N 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 239000012533 medium component Substances 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- 210000005037 parasympathetic nerve Anatomy 0.000 description 2
- 238000004161 plant tissue culture Methods 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- NHZMQXZHNVQTQA-UHFFFAOYSA-N pyridoxamine Chemical compound CC1=NC=C(CO)C(CN)=C1O NHZMQXZHNVQTQA-UHFFFAOYSA-N 0.000 description 2
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- 229940011671 vitamin b6 Drugs 0.000 description 2
- HXKWSTRRCHTUEC-UHFFFAOYSA-N 2,4-Dichlorophenoxyaceticacid Chemical compound OC(=O)C(Cl)OC1=CC=C(Cl)C=C1 HXKWSTRRCHTUEC-UHFFFAOYSA-N 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- HABAPWZXRLIZDL-UHFFFAOYSA-N 2-chloro-2-phenoxyacetic acid Chemical compound OC(=O)C(Cl)OC1=CC=CC=C1 HABAPWZXRLIZDL-UHFFFAOYSA-N 0.000 description 1
- 241000589156 Agrobacterium rhizogenes Species 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 241001465356 Atropa belladonna Species 0.000 description 1
- 229930192334 Auxin Natural products 0.000 description 1
- 101100063251 Bacillus subtilis (strain 168) desR gene Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 241000208278 Hyoscyamus Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- FAIXYKHYOGVFKA-UHFFFAOYSA-N Kinetin Natural products N=1C=NC=2N=CNC=2C=1N(C)C1=CC=CO1 FAIXYKHYOGVFKA-UHFFFAOYSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 241000122904 Mucuna Species 0.000 description 1
- 241000824634 Myopa Species 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241000206609 Porphyra Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000242873 Scopolia Species 0.000 description 1
- 241000242847 Scopolia japonica Species 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 241000208292 Solanaceae Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000002921 anti-spasmodic effect Effects 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000002363 auxin Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- GVPFVAHMJGGAJG-UHFFFAOYSA-L cobalt dichloride Chemical compound [Cl-].[Cl-].[Co+2] GVPFVAHMJGGAJG-UHFFFAOYSA-L 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- RUTXIHLAWFEWGM-UHFFFAOYSA-H iron(3+) sulfate Chemical compound [Fe+3].[Fe+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O RUTXIHLAWFEWGM-UHFFFAOYSA-H 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 229910000360 iron(III) sulfate Inorganic materials 0.000 description 1
- QANMHLXAZMSUEX-UHFFFAOYSA-N kinetin Chemical compound N=1C=NC=2N=CNC=2C=1NCC1=CC=CO1 QANMHLXAZMSUEX-UHFFFAOYSA-N 0.000 description 1
- 229960001669 kinetin Drugs 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 235000011147 magnesium chloride Nutrition 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- SCIFESDRCALIIM-UHFFFAOYSA-N n-methylphenylalanine Chemical compound CNC(C(O)=O)CC1=CC=CC=C1 SCIFESDRCALIIM-UHFFFAOYSA-N 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 150000003138 primary alcohols Chemical class 0.000 description 1
- 229960003581 pyridoxal Drugs 0.000 description 1
- 235000008164 pyridoxal Nutrition 0.000 description 1
- 239000011674 pyridoxal Substances 0.000 description 1
- 235000008151 pyridoxamine Nutrition 0.000 description 1
- 239000011699 pyridoxamine Substances 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 210000004894 snout Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011684 sodium molybdate Substances 0.000 description 1
- 235000015393 sodium molybdate Nutrition 0.000 description 1
- TVXXNOYZHKPKGW-UHFFFAOYSA-N sodium molybdate (anhydrous) Chemical compound [Na+].[Na+].[O-][Mo]([O-])(=O)=O TVXXNOYZHKPKGW-UHFFFAOYSA-N 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- UZKQTCBAMSWPJD-UQCOIBPSSA-N trans-Zeatin Natural products OCC(/C)=C\CNC1=NC=NC2=C1N=CN2 UZKQTCBAMSWPJD-UQCOIBPSSA-N 0.000 description 1
- UZKQTCBAMSWPJD-FARCUNLSSA-N trans-zeatin Chemical compound OCC(/C)=C/CNC1=NC=NC2=C1N=CN2 UZKQTCBAMSWPJD-FARCUNLSSA-N 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 229940023877 zeatin Drugs 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
Landscapes
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明はズボイシア、ダツラ、ハシリドコロ、ヒヨス等
のトロパン系アルカロイドを代謝産生ずる植物の組織を
特定の培地を用いて組織培養することによりスコポラミ
ンおよび/又はヒヨスチアミン等のトロパン系アルカロ
イドを製造する方法に関する。Detailed Description of the Invention [Industrial Application Field] The present invention produces scopolamine and The present invention relates to a method for producing a tropane alkaloid such as hyoscyamine.
トロパン系アルカロイドについては、スコポラミンは鎮
痙剤、鎮痛剤および副交感神経しゃ新薬として、またヒ
ヨスチアミンは副交感神経しゃ新薬として、それぞれ医
薬として重用されている。Among the tropane-based alkaloids, scopolamine is used as an antispasmodic, analgesic, and a new parasympathetic nerve suppressant, and hyoscyamine is used as a new parasympathetic nerve suppressant.
これらの化合物は、天然の植物体中から抽出して製造さ
れているが、天然物を原料としているため、その生産が
天候に左右されること、収穫時期が限定されていること
などが問題となっている。そのためこれらの化合物を植
物の組織培養により生産する研究が内外で数多く行われ
た。カルスによる生産では、山田らによるヒヨスのカル
スによる生産例が知られている( Plant Ce1
l Reports上、101〜103(1982)
)が、スコポラミン含量は20ppmと、天然の植物体
中の含量と比較して低いものであった。また山田らは、
ズボイシア(Duboisia Le−ichhard
tii P、Muell)の組織培養により得られる不
定根中に著量のスコポラミンおよびヒヨスチアミンが存
在することを見出している[ Plant Ce1lR
eports i、186〜188(1984) )が
、その量はまだ充分とは言えないものであった。そこで
、ズボイシア不定根の各種培養条件を検討し、培地のア
ンモニウムイオンと硝酸イオンの比率を0.2以上にす
ること、培地の溶存酸素濃度を10ないし65ppmと
することにより、トロパン系アルカロイドの生産性を向
上させることを見出し、本出願人はそれぞれ特願昭60
−143882号および特願昭60−143881号と
して特許出願しているが、工業的な見地からはその生産
性を更に高めることが望まれる。These compounds are manufactured by extracting them from natural plants, but because they are made from natural materials, there are problems such as their production being affected by the weather and the harvesting period being limited. It has become. Therefore, many studies have been conducted both domestically and internationally to produce these compounds through plant tissue culture. Regarding production by callus, an example of production by Yamada et al. using henbane callus is known (Plant Ce1
l Reports, 101-103 (1982)
), but the scopolamine content was 20 ppm, which was lower than the content in natural plants. Also, Yamada et al.
Duboisia Le-ichhard
It has been found that significant amounts of scopolamine and hyoscyamine are present in adventitious roots obtained by tissue culture of Plant Ce1lR).
eports i, 186-188 (1984)), but the amount was still not sufficient. Therefore, we investigated various culture conditions for Zboisia adventitious roots, and by setting the ratio of ammonium ions to nitrate ions in the medium to 0.2 or higher and the dissolved oxygen concentration in the medium to 10 to 65 ppm, we improved the productivity of tropane-based alkaloids. The present applicant has each filed a patent application in 1986.
Although patent applications have been filed as No. 143882 and Japanese Patent Application No. 143881/1988, it is desired to further increase the productivity from an industrial standpoint.
したがってこのような組織培養によりトロパン系アルカ
ロイドの工業的な生産を目指す場合、さらに生産性を高
めることが重要な課題であった。Therefore, when aiming at industrial production of tropane-based alkaloids using such tissue culture, it has been an important issue to further increase productivity.
このような事情にかんがみ、本発明者らは、ズボイシア
、ダツラ、ハシリドコロおよびヒヨス属等のトロパン系
アルカロイドを産生ずる植物の不定根等の組織、細胞を
効率よく培養する方法を研究した結果、次のような事実
を見出した。In view of these circumstances, the present inventors have researched methods for efficiently cultivating tissues and cells such as adventitious roots of plants that produce tropane alkaloids, such as Zboisia, Datura, Porphyra, and Hyosus, and have found the following. I found such a fact.
すなわちトロパン系アルカロイドを産生ずる植物の組織
を、特定のアミノ酸を特定の濃度で含有する培地を用い
て組織培養を行うと、得られる培養細胞あるいは不定根
等の培養によって得られる培養組織中のトロパン系アル
カロイドの含量が向上するか、あるいは培養細胞、不定
根等の培養組繊の生育が促進され、結果としてトロパン
系アルカロイドの生産性が向上することを見出し本発明
を完成するに到った。In other words, when tissues of plants that produce tropane-based alkaloids are cultured using a medium containing specific amino acids at specific concentrations, tropane-based alkaloids are produced in cultured cells or cultured tissue obtained by culturing adventitious roots. The inventors have now completed the present invention by discovering that the alkaloid content is increased or the growth of cultured tissue fibers such as cultured cells and adventitious roots is promoted, resulting in improved productivity of tropane alkaloids.
すなわち、本発明によれば、トロパン系アルカロイドを
産生ずる植物の組織をフェニルアラニン誘゛導体を1.
0.uM以上含有する培地を用いて組織培養してトロパ
ン系アルカロイドを生産すること ゛を特徴とする
トロパン系アルカロイドの生産方法が提供される。That is, according to the present invention, the tissue of a plant that produces tropane alkaloids is treated with a phenylalanine derivative in 1.
0. Provided is a method for producing tropane alkaloids, which comprises producing tropane alkaloids by culturing tissue using a medium containing at least uM.
本発明では組織培養はトロパン系アルカロイドを産生ず
る植物を用いて行われるが、該当する植物として具体的
には、ズボイシア・ミオポロイデス(Duboisia
5yoporoides)+ ズボイシア・ライヒハ
ルデ4 (Duboisia 1eichhardti
i)等のズボイシア属植物、ダツラ・ダツラ(Datu
ra tatuJa)+ ダツラ・アルボレア(Dat
ura arborea)+ ダツラ・ストラモニウム
(Datura strawonius)等のダツラ属
植物、スコボリア・ジャポニカ(Scopolia j
aponica)等のスコボリア属植物、ヒョシアマス
ニガー(Iyoscyan+us niger)等のヒ
ヨス属植物およびアトローパ・ベラドンナ(^trop
a belladonna)等のアトローパ属植物など
のナス科植物を例示することができる。In the present invention, tissue culture is carried out using plants that produce tropane-based alkaloids.
5yoporoides) + Duboisia 1eichhardti 4 (Duboisia 1eichhardti)
i) and other plants of the genus Zboisia, Datu
ra tatuJa) + Datura arborea (Dat
ura arborea) + plants of the genus Datura such as Datura strawonius, Scopolia japonica (Scopolia j
aponica), plants of the genus Mucuna such as Iyoscyan+us niger, and Atropa belladonna (^trop).
Examples include plants of the Solanaceae family, such as plants of the genus Atropa such as A belladonna).
本発明では前記・植物の組織を培養してトロパン系アル
カロイドを生産するに当たってフェニルアラニン誘導体
を1.0μh以上含有する培地が用いられる。以下これ
について詳述する。In the present invention, a medium containing 1.0 .mu.h or more of a phenylalanine derivative is used to produce tropane alkaloids by culturing the aforementioned plant tissues. This will be explained in detail below.
本発明で使用される培地はフェニルアラニン誘導体を必
須成分として含む培地であって、該成分以外の他の成分
として無機成分および炭素源を必須成分とし、これに植
物ホルモン類、ビタミン類を添加し、更に必要に応じて
本発明に係わるフェニルアラニン誘導体以外の他のグリ
シン、グルタミン酸、リジン等のアミノ酸類を添加して
もよい培地である。The medium used in the present invention is a medium containing a phenylalanine derivative as an essential component, and other components other than this component include an inorganic component and a carbon source, to which plant hormones and vitamins are added, Furthermore, it is a medium to which amino acids other than the phenylalanine derivative according to the present invention, such as glycine, glutamic acid, and lysine, may be added as necessary.
本発明に係わるフェニルアラニン誘導体は一般式(1)
%式%(1)
〔式中、RIは低級アルキル基又はハロゲン原子を示し
、9tはH又はR−C−(RはH又は低級アルキル基)
を示し、R3はOL NiF!又0?f (Mは金属イ
オンを示す)であり、nは工ないし3の整数を示す、〕
で表わされるアミノ酸の誘導体であって、具体的には4
−メチル−フェニルアラニン等のアルキルフェニルアラ
ニン、4−クロロフェニルアラニン、4−フルオロフェ
ニルアラニン等のハロゲン化フェニルアラニン、4−フ
ルオロフ。The phenylalanine derivative according to the present invention has the general formula (1) % formula % (1) [In the formula, RI represents a lower alkyl group or a halogen atom, and 9t is H or R-C- (R is H or a lower alkyl group)
and R3 is OL NiF! 0 again? f (M represents a metal ion), n represents an integer of 0 to 3,]
It is a derivative of the amino acid represented by 4, specifically 4
- Alkylphenylalanine such as methyl-phenylalanine, halogenated phenylalanine such as 4-chlorophenylalanine, 4-fluorophenylalanine, 4-fluorof.
エニルアラニンアミド等のアミド誘導体を例示できる0
本発明ではこれら化合物のうち該化合物中のカルボキシ
ル基が培地を構成する後述の無機成分と同じ金属イオン
と塩を形成していても良く、本発明ではこの塩も培地成
分として使用できる。Examples include amide derivatives such as enylalanine amide.
In the present invention, the carboxyl group in these compounds may form a salt with the same metal ion as the below-mentioned inorganic component constituting the medium, and this salt can also be used as a medium component in the present invention.
本発明では、培地に含まれる前記したフェニルアラニン
誘導体の使用割合は1.0μM以上である。In the present invention, the proportion of the above-mentioned phenylalanine derivative contained in the medium is 1.0 μM or more.
該範囲の中でも、2μM〜30μMの範囲が特に好まし
い。フェニルアラニン誘導体濃度の上限は通常1n+M
である。培地中のフェニルアラニン誘導体の含有量が1
.0μ門未満である場合には、このような培地を用いて
組織培養を行ってもトロパン系アルカロイドの生成量は
それ程向上しないので、本発明では該成分の含有量を前
記範囲にした培地を用いて組織培養が行われる。Among these ranges, a range of 2 μM to 30 μM is particularly preferred. The upper limit of phenylalanine derivative concentration is usually 1n+M
It is. The content of phenylalanine derivatives in the medium is 1
.. If the concentration is less than 0μ, the amount of tropane alkaloid produced will not improve significantly even if tissue culture is performed using such a medium. Therefore, in the present invention, a medium with the content of this component within the above range is used. Tissue culture is performed.
本発明で使用される培地において、前記したフェニルア
ラニン誘導体以外の他の培地成分については、無機成分
として、窒素、リン、カリウム、ナトリウム、カルシウ
ム、マグネシウム、イオウ、鉄、マンガン、亜鉛、ホウ
素、モリブデン、塩素、ヨウ素、コバルト等の元素を含
む無機塩を挙げることができ、具体的には硝酸カリウム
、硝酸ナトリウム、硝酸アンモニウム、塩化アンモニウ
ム、塩化カリウム、塩化カルシウム、リン酸1水素カリ
ウム、リン酸2水素カリウム、硫酸マグネシウム、塩化
マグネシウム、硫酸ナトリウム、硫酸第1鉄、硫酸第2
鉄、硫酸マンガン、硫酸銅、モリブデン酸ナトリウム、
二酸化モリブデン、ヨウ化カリウム、硫酸亜鉛、ホウ酸
、塩化コバルト等の化合物を例示できる。In the medium used in the present invention, other medium components other than the above-mentioned phenylalanine derivatives include nitrogen, phosphorus, potassium, sodium, calcium, magnesium, sulfur, iron, manganese, zinc, boron, molybdenum, Examples include inorganic salts containing elements such as chlorine, iodine, and cobalt; specific examples include potassium nitrate, sodium nitrate, ammonium nitrate, ammonium chloride, potassium chloride, calcium chloride, potassium monohydrogen phosphate, potassium dihydrogen phosphate, Magnesium sulfate, magnesium chloride, sodium sulfate, ferrous sulfate, ferric sulfate
Iron, manganese sulfate, copper sulfate, sodium molybdate,
Examples include compounds such as molybdenum dioxide, potassium iodide, zinc sulfate, boric acid, and cobalt chloride.
該培地の炭素源としては、ショ糖等の炭水化物とその誘
導体、脂肪酸等の有機酸およびエタノール等の1級アル
コールなどを例示できる。Examples of carbon sources for the medium include carbohydrates such as sucrose and derivatives thereof, organic acids such as fatty acids, and primary alcohols such as ethanol.
該培地の植物ホルモン類としては、例えば、ナフタレン
酢酸(NA^)、インドール酢fi(IAA) 、p−
クロロフェノキシ酢酸、2.4−ジクロロフェノキシ酢
酸(2,4−D)、インドール酪酸(IBM)およびこ
れらの誘導体等のオーキシン類およびベンジルアデニン
(BA)、カイネチン、ゼアチン等のサイトカイニン類
を例示できる。本発明ではサイトカイニン類は通常は培
地に添加しないことが望ましいが、必要に応じて添加す
る場合にはサイトカイニン類は濃度が通常10−’M(
0,02■/l)以下の低濃度で使用することが好まし
い。Examples of the plant hormones in the medium include naphthalene acetic acid (NA^), indole vinegar fi (IAA), p-
Examples include auxins such as chlorophenoxyacetic acid, 2,4-dichlorophenoxyacetic acid (2,4-D), indolebutyric acid (IBM), and derivatives thereof, and cytokinins such as benzyladenine (BA), kinetin, and zeatin. In the present invention, it is generally preferable not to add cytokinins to the culture medium, but when added as necessary, the concentration of cytokinins is usually 10-'M (
It is preferable to use it at a low concentration of 0.02 ■/l) or less.
該培地のビタミン類としては、ビオチン、チアミン(ビ
タミンB+)、ピリドキシン(ビタミンB6)、ピリド
キサール、ピリドキサミン、パントテン酸カルシウム、
アスコルビン酸(ビタミンC)、イノシトール、ニコチ
ン酸、ニコチン酸アミドおよびリボフラビン(ビタミン
fh)などを例示できる。The vitamins in the medium include biotin, thiamine (vitamin B+), pyridoxine (vitamin B6), pyridoxal, pyridoxamine, calcium pantothenate,
Examples include ascorbic acid (vitamin C), inositol, nicotinic acid, nicotinamide, and riboflavin (vitamin fh).
本発明の前記培地は、通常は、前記無機成分を約0.1
μ門ないし約1100II、前記炭素源を約1g/lな
いし約100g//!、前記植物ホルモン類を約0.0
1μ門ないし約100μi、前記ビタミン類を約0.1
■/lないし約150B//!含ませて使用されること
が望ましい。The medium of the present invention usually contains about 0.1 of the inorganic components.
μ gate to about 1100 II, and about 1 g/l to about 100 g// of said carbon source! , about 0.0 of the plant hormones
1 μm to about 100 μi, and about 0.1 μm of the above vitamins.
■/l or about 150B//! It is desirable to use it together.
本発明のズボイシア属植物の組織培養に用いられる前記
培地として具体的には、従来から知られている植物の組
織培養に用いられている培地、例えば、ムラシゲ・スク
ーグ(’62) (Murashige &Skoo
g )の培地、リンスマイヤー・スクーグ(RM−19
65) (Linsmaier & Skoog )
の培地、ホワイト(’63) (White)の培地、
ガンボルグ(Gamborg)のB−5培地、三井のM
−9培地、ニッチ・エッチ(Nitsch N1tsc
h )の培地等に本発明に係わるフェニルアラニン誘導
体及び前記した炭素源および植物ホルモンを添加し、更
に必要に応じて前記したビタミン類等を添加して調製さ
れる培地を例示できるが、本発明ではこの中でも特にエ
ッチ・エッチ、リンスマイヤー・スクーグ又はムラシゲ
・スクーグの培地を用いて調製される培地が好ましい。Specifically, the medium used for the tissue culture of plants belonging to the genus Zboisia of the present invention includes a conventionally known culture medium used for tissue culture of plants, such as Murashige & Skoo ('62).
g) medium, Linsmeyer-Skoog (RM-19
65) (Linsmaier & Skoog)
medium, white medium ('63),
Gamborg's B-5 medium, Mitsui's M
-9 medium, Nitsch N1tsc
An example of a culture medium prepared by adding the phenylalanine derivative according to the present invention, the above-mentioned carbon source and plant hormone to the medium etc. of h), and further adding the above-mentioned vitamins etc. as necessary; Among these, media prepared using H-H, Linsmeyer-Skoog, or Murashige-Skoog are particularly preferred.
なお、上記した従来公知の培地の組成に関しては、例え
ば、性向、中島、古谷著の[新植物組織培養J P38
6〜P391、朝倉書店、1979年に記載されている
。Regarding the composition of the above-mentioned conventionally known culture medium, for example, see [New Plant Tissue Culture J P38] by Tenshi, Nakajima, and Furuya.
6-P391, Asakura Shoten, 1979.
本発明で使用できる前記培地は液体培地又は寒天やゼラ
チン等を通常0.5〜1%含有させた固型培地であるが
本発明では液体培地を用いることが好ましい。The medium that can be used in the present invention is a liquid medium or a solid medium containing usually 0.5 to 1% of agar, gelatin, etc., but it is preferable to use a liquid medium in the present invention.
本発明の組織培養ではトロパン系アルカロイドを代謝産
生ずる植物の組織片は、前記培地を用いて組織培養され
てトロパン系アルカロイドを含有する培養細胞ないし培
養組織が得られる。In the tissue culture of the present invention, tissue pieces of plants that metabolize tropane alkaloids are tissue cultured using the above medium to obtain cultured cells or cultured tissues containing tropane alkaloids.
本発明では該培養組織としては不定根が特に好ましい。In the present invention, adventitious roots are particularly preferred as the cultured tissue.
本発明の組織培養に用いられる前記植物の組織として具
体的には、該植物の根、葉、茎、種子、花芽などの他に
も本発明に係わる組織培養あるいは他の従来の組織培養
方法によって得られる該植物の培養細胞ないし培養組織
を例示できる。本発明では、これらの中では植物組織を
前もって組織培養して得られる不定根を使用してこれを
本発明に係わる培地を用いて組織培養することが特に好
ましく、この場合には原料の不定根が本発明の培地を用
いて゛増殖培養されてトロパン系アルカロイドを多量含
有する不定根が得られる。Specifically, the tissues of the plants used in the tissue culture of the present invention include roots, leaves, stems, seeds, flower buds, etc. of the plants, as well as those that can be used in the tissue culture of the present invention or other conventional tissue culture methods. The resulting cultured cells or tissue of the plant can be exemplified. In the present invention, among these, it is particularly preferable to use adventitious roots obtained by previously tissue culturing plant tissues and tissue culture them using the medium according to the present invention. In this case, the adventitious roots as raw materials are Adventitious roots containing a large amount of tropane alkaloids can be obtained by propagation and culture using the medium of the invention.
本発明では通常、前記した組織片あるいは細胞からカル
スが誘導され、該カルスを継代培養して得られる培養細
胞ないしは培養′MAmを本発明の前記培地を用いて増
殖培養しトロパン系アルカロイドを多量含有する培養物
、特に不定根を得るというような組織培養の方法を用い
ることが好ましい。In the present invention, callus is usually induced from the above-described tissue pieces or cells, and cultured cells or cultured MAm obtained by subculturing the callus are grown and cultured using the above-mentioned medium of the present invention to obtain a large amount of tropane-based alkaloids. Preference is given to using methods of tissue culture, such as obtaining cultures containing, in particular adventitious roots.
本発明では不定根を用いる場合に、植物の組織片を例え
ば毛根病菌(例えばAgrobacteriua+rh
izogenes)で感染させ、これによって出現する
毛根を用いることもできる(例えば本出願人に係わる特
開昭62−248429号で提案した方法を用いること
もできる。)
本発明の方法によって得られるトロパン系アルカロイド
として具体的には、スコポラミン、ヒヨスチアミン及び
これらの化合物のアセチル化合物を例示できるが、この
中ではスコポラミンとヒヨスチアミンが好ましい。In the present invention, when using adventitious roots, plant tissue pieces may be treated with hairy root disease bacteria (e.g., Agrobacteria+rh).
zogenes) and the resulting hair roots can be used (for example, the method proposed in Japanese Unexamined Patent Publication No. 62-248429 filed by the present applicant can also be used). Specific examples of the alkaloid include scopolamine, hyoscyamine, and acetyl compounds of these compounds, and among these, scopolamine and hyoscyamine are preferred.
本発明ではトロパン系アルカロイドを含有する培養細胞
から該アルカロイドを分離する方法とし゛ては、例えば
薬局法等に記載されている、トロパン系アルカロイドを
含有する植物からこれら化合物を単離精製する場合に用
いられてきた通常の方法を採用することができる。In the present invention, the method for separating tropane-based alkaloids from cultured cells containing them is a method that can be used, for example, when isolating and purifying tropane-based alkaloids from plants containing tropane-based alkaloids, as described in the Pharmacopoeia Act. The usual methods that have been used can be adopted.
以下、本発明の方法を実施例によって更に具体的に説明
する。Hereinafter, the method of the present invention will be explained in more detail with reference to Examples.
実施例1.2.3.4
当社薬草園にて栽培したDabofsia myopa
ro+desR,Brの葉を洗浄し、10%アンチホル
ミン液に1〇分間浸漬し、次いで滅菌水で3回洗浄した
後、約1cmに切断し、ナフタレン酢酸およびベンジル
アデニンをそれぞれ10−’Mおよび1〇−吻となるよ
うに添加したリンスマイヤー・スクーグの寒天培地に置
床し、25℃で30日間培養する。カルス形成と同時に
発生した不定根を切り出し、インドール酪酸を10−%
Hになるように添加したエッチ・エッチの液体培地に移
植し、2年間継代培養した。このようにして得た不定根
10■(乾燥重量)をインドール酪酸を10−’Hにな
るように添加したエッチ・ニッチの液体培地20−を含
む10〇−容の三角フラスコに移植して培養開始時に4
−フルオロフェニルアラニン濃度が各々1μM、3μ’
M 、 10μM及び30μMとなるように4−フルオ
ロフェニルアラニンを先の液体培地に添加して、さらに
3週間振とう培養した。得られた不定根を乾燥後、−基
性のクロロホルム−メタノール液50−で抽出した。こ
れに40@lのIN硫酸を加えてアルカロイド層を硫酸
層に移した。さらに、アンモニア水2−およびクロロホ
ルム40tdを加えてアルカロイドをクロロホルム層に
移し、これを減圧濃縮し、ガスクロマトグラフでアルカ
ロイド量を分析した。この場合のアルカロイドの生産量
を表1に示した。なお、ガスクロマトグラフの分析は以
下の条件で行った。Example 1.2.3.4 Dabofsia myopa grown in our herb garden
ro+desR,Br leaves were washed, immersed in 10% antiformin solution for 10 minutes, then washed three times with sterile water, cut into approximately 1 cm pieces, and treated with naphthaleneacetic acid and benzyladenine at 10-'M and 1, respectively. 〇-Place on Linsmeyer-Skoog agar medium added so as to form a snout, and culture at 25°C for 30 days. Cut out the adventitious roots that occurred at the same time as callus formation, and add 10% indolebutyric acid.
The cells were transplanted into a liquid medium of H.H. and subcultured for 2 years. Culture was started by transplanting 10 cm (dry weight) of the adventitious roots thus obtained into a 100-volume Erlenmeyer flask containing 20-cm of Etch Niche liquid medium supplemented with indolebutyric acid to a concentration of 10-'H. sometimes 4
- Fluorophenylalanine concentrations are 1 μM and 3 μ', respectively.
4-Fluorophenylalanine was added to the above liquid medium to give M, 10 μM and 30 μM, and cultured with shaking for an additional 3 weeks. The obtained adventitious roots were dried and then extracted with 50% of a basic chloroform-methanol solution. 40@l of IN sulfuric acid was added to this and the alkaloid layer was transferred to the sulfuric acid layer. Furthermore, ammonia water 2- and chloroform 40 td were added to transfer the alkaloids to the chloroform layer, which was concentrated under reduced pressure and the amount of alkaloids was analyzed using a gas chromatograph. Table 1 shows the production amount of alkaloid in this case. Note that the gas chromatograph analysis was conducted under the following conditions.
カラム: 5ilicone QV−17(1%) o
nChroa+osorb W (Mesh 8ON1
00)3msφX1a+ガラスカラム
キ□ヤリャガス“:N!
カラム温度 : 200℃
比較例1
実mN1において4−フルオロ−フェニルアラニンを添
加しない培地を用いた以外は該実施例と同様に行った結
果を表1に示した。Column: 5ilicone QV-17 (1%) o
nChroa+osorb W (Mesh 8ON1
00) 3ms φ Indicated.
比較例2
実施例1において4−フルオロ−フェニルアラニン濃度
を0.05μMとした以外は該実施例と同様に行った結
果を表1に示した。Comparative Example 2 Table 1 shows the results of carrying out the same procedure as in Example 1 except that the 4-fluoro-phenylalanine concentration was changed to 0.05 μM.
(本貫以下余白)
実施例5.6.7
ズボイシア(Duboisia myoporoide
s R,Br)の葉を10%アンチホルミンで処理した
のち、ベンジルアデニン10−’Mを含むリンスマイヤ
ー・スクーグ(LS)の寒天培地に置床した。1ケ月後
発生した苗条を同じ培地で40日日間化培養して得られ
るまだ本化していないズボイシア苗条の茎を1〜2CI
11程度切断し、24時間振とう培養した
Agrobacterium rhizogenes
HRI−1の懸濁液(107個/ml)に浸漬後、植物
ホルモンを含まないLS寒天培地に置床した。3週間後
面条の茎の切断部位から不定根が発生した。これをアン
ピシリン0.1 mg/mI含むLS液体培地で2日間
処理し菌を含まない自己増殖性のズボイシア感染不定根
を得た。このズボイシア感染不定根をLS液体培地で1
年間継代培養した。この不定根10■(乾燥重りを4−
フルオロフェニルアラニン4度が各々3μM 、 10
μ阿、30μ−になるように添加したLS液体培地20
mZを含む100 m容三角フラスコに移植し、3週間
振とう培養した。得られた不定根を乾燥し、実施例1と
同じ方法で抽出し、アルカロイド量を分析した。この場
合のアルカロイドの生産量を表2に示した。(Margins below main text) Example 5.6.7 Duboisia myoporoid
After treating the leaves of s R, Br) with 10% antiformin, they were placed on a Linsmeyer-Skoog (LS) agar medium containing 10-'M benzyladenine. The shoots that emerged after 1 month were cultured for 40 days in the same medium, and the stems of the Zboisia shoots, which had not yet matured, were cultured at 1 to 2 CI.
Agrobacterium rhizogenes cut into about 11 pieces and cultured with shaking for 24 hours
After being immersed in a suspension of HRI-1 (10 7 cells/ml), the cells were placed on an LS agar medium containing no plant hormones. After 3 weeks, adventitious roots developed from the cut site of the stem of the surface streak. This was treated with an LS liquid medium containing 0.1 mg/mI of ampicillin for 2 days to obtain bacteria-free, self-propagating adventitious roots infected with Zboisia. This Zboisia-infected adventitious root was grown in LS liquid medium.
It was subcultured for a year. This adventitious root 10■ (dry weight 4-
Fluorophenylalanine 4 degrees is 3 μM each, 10
μA, LS liquid medium 20 added to 30 μ-
The cells were transplanted into a 100 m Erlenmeyer flask containing mZ and cultured with shaking for 3 weeks. The obtained adventitious roots were dried, extracted in the same manner as in Example 1, and analyzed for alkaloid content. Table 2 shows the production amount of alkaloid in this case.
比較例1
実施例5において4−フルオロフェニルアラニンを添加
しなかった以外は該実施例と同様に行った結果を表2に
示した。Comparative Example 1 Table 2 shows the results of the same procedure as in Example 5 except that 4-fluorophenylalanine was not added.
比較例2
実施例5において4−フルオロフェニルアラニン濃度を
1μ門とした以外は該実施例と同様に行った結果を表2
に示した。Comparative Example 2 Table 2 shows the results of the same procedure as in Example 5 except that the 4-fluorophenylalanine concentration was changed to 1 μm.
It was shown to.
(本頁以下余白)
実施例8,9.10
実施例1と同様にして得られた不定根10■を、4−ク
ロロフェニルアラニン濃度が各々、3μN、10μN及
び30#Mとなる様に添加し、又インドール酪酸を10
−jMとなる様に添加したエッチ・ニッチの液体培地2
011を含む1ooId容の三角フラスコに移植した。(Margin below this page) Examples 8, 9.10 10 cm of adventitious roots obtained in the same manner as in Example 1 were added so that the 4-chlorophenylalanine concentrations were 3 μN, 10 μN, and 30 #M, respectively. Also, indolebutyric acid 10
-Etch Niche liquid medium 2 added so that jM
011 into a 1 ooId volume Erlenmeyer flask.
3週間培養後、実施例1と同様に処理し、アルカロイド
量を分析した。この場合のアルカロイド生産量を表3に
示す。After culturing for 3 weeks, the cells were treated in the same manner as in Example 1, and the amount of alkaloid was analyzed. Table 3 shows the alkaloid production amount in this case.
比較例1
実施msにおいて4−クロロフェニルアラニンを添加し
なかった以外は該実施例と同様に行った結果を表3に示
した。Comparative Example 1 Table 3 shows the results of the same procedure as in Example 1 except that 4-chlorophenylalanine was not added in the sample.
比較例2
実施例8において4−クロロフェニルアラニン濃度を0
.5IIMとした以外は該実施例と同様に行った結果を
表3に示した。−
(来夏以下余白)
〔発明の効果〕
本発明の組織培養によるトロパン系アルカロイドの生産
方法を採用すれば、従来法に比べてトロパン系アルカロ
イドを、中でも特にスコポラミンおよび/又はヒヨスチ
アミンを大量に効率よ(生産することができる。 ・
出願人 生体機能利用化学品新製造技術研究組合代理人
弁理士 平 木 祐 輔Comparative Example 2 In Example 8, the 4-chlorophenylalanine concentration was 0.
.. Table 3 shows the results obtained in the same manner as in the example except that 5IIM was used. - (Blank below next summer) [Effects of the invention] If the method for producing tropane alkaloids by tissue culture of the present invention is adopted, tropane alkaloids, especially scopolamine and/or hyoscyamine, can be produced in large quantities compared to conventional methods. Efficiency (can be produced.) - Applicant: New Manufacturing Technology Research Association for Chemicals Utilizing Biofunctions, Patent Attorney: Yusuke Hiraki
Claims (1)
フェニルアラニン誘導体を1.0μM以上含有する培地
を用いて組織培養してトロパン系アルカロイドを生産す
ることを特徴とするトロパン系アルカロイドの生産方法
。(1) A method for producing tropane alkaloids, which comprises culturing the tissue of a plant that produces tropane alkaloids using a medium containing 1.0 μM or more of a phenylalanine derivative to produce tropane alkaloids.
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4223388A JPH01218595A (en) | 1988-02-26 | 1988-02-26 | Production of tropan-based alkaloid |
KR1019890002230A KR890013171A (en) | 1988-02-26 | 1989-02-25 | Production Method of Tropan Alkaloids |
AU30784/89A AU3078489A (en) | 1988-02-26 | 1989-02-27 | Method for producing tropane alkaloid |
EP89301942A EP0331404A3 (en) | 1988-02-26 | 1989-02-27 | Method for producing tropane alkaloid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4223388A JPH01218595A (en) | 1988-02-26 | 1988-02-26 | Production of tropan-based alkaloid |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH01218595A true JPH01218595A (en) | 1989-08-31 |
Family
ID=12630315
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP4223388A Pending JPH01218595A (en) | 1988-02-26 | 1988-02-26 | Production of tropan-based alkaloid |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH01218595A (en) |
-
1988
- 1988-02-26 JP JP4223388A patent/JPH01218595A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH05219974A (en) | Production of tropane alkaloid | |
JPH01218595A (en) | Production of tropan-based alkaloid | |
JPH01124383A (en) | Tissue culture of plant | |
JPH01240194A (en) | Production of tropane-based alkaloid | |
JPH02117393A (en) | Production of tropane alkaloid | |
JPH0220291A (en) | Production of tropane-type alkaloid | |
EP0331404A2 (en) | Method for producing tropane alkaloid | |
JPS63167793A (en) | Production of tropane based alkaloid | |
JP2703783B2 (en) | Triterpenoid production method | |
JPS63129989A (en) | Production of tropane alkaloid | |
JPS6387991A (en) | Production of tropane-type alkaloid | |
JPH01243995A (en) | Production of tropane based alkaloid | |
JPH01300890A (en) | Cell capable of highly producing tropane-based alkaloid and production of said cell | |
JPS6339595A (en) | Production of alkaloid | |
JPS6384497A (en) | Production of tropan based alkaloid | |
JPH02303431A (en) | Production of tropane-based alkaloid | |
JPH01273597A (en) | Production of tropan based alkaloid | |
JPS626674A (en) | Method of tissue culture for plant of genus duboisia | |
JPS63226281A (en) | Tissue culture method | |
JPH02303430A (en) | Method for carrying out tissue culture of adventive root of tropane-based alkaloid producing plant | |
JPS626675A (en) | Method of tissue culture for duboisia leichhardtu f. muell | |
JPS63167790A (en) | Tissure culture | |
JPH01165391A (en) | Production of berberine type alkaloid | |
JPH01269430A (en) | Method and propagating shoot of plant belonging to genus rosa | |
JPS63116691A (en) | Tissue cultivation method for plant |